Back to REGN
WEDGE CAPITAL MANAGEMENT L L P/NC → REGN
WEDGE CAPITAL MANAGEMENT L L P/NC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$25.6M
Q3 2026
Peak value
$31.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $31.9M |
| Q1 2026 | $30.7M |
| Q2 2026 | $29.8M |
| Q3 2026 | $25.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $25.6M | 33.7K | — | — |
| Q2 2026 | $29.8M | 47.8K | — | — |
| Q1 2026 | $30.7M | 39.7K | — | — |
| Q4 2025 | $31.9M | 41.3K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B